(Q40405171)

20 September 2017

title

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo (English)

1 reference

evasion of host immune response

20 September 2017

main subject

1 reference

5

Michael Weller

1 reference

20 September 2017

3

Michel Mittelbronn

1 reference

20 September 2017

4

Richard Meyermann

1 reference

20 September 2017

1

Jörg Wischhusen

1 reference

20 September 2017

Manuel A Friese

2

1 reference

20 September 2017

publication date

1 June 2005

1 reference

Journal of Neuropathology & Experimental Neurology

20 September 2017

published in

1 reference

20 September 2017

volume

64

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

523-528

1 reference

The three Es of cancer immunoediting

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

The role of CD94/NKG2 in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Analysis of regulatory CD8 T cells in Qa-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.6.523

21 January 2018

Identifiers

DOI

10.1093/JNEN/64.6.523

1 reference

20 September 2017

1 reference